Cumberland Pharmaceuticals
CPIX
26 hedge funds and large institutions have $13.2M invested in Cumberland Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.
78% more capital invested
Capital invested by funds: $7.43M → $13.2M (+$5.8M)
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
13% more funds holding
Funds holding: 23 → 26 (+3)
0.61% more ownership
Funds ownership: 18.6% → 19.21% (+0.61%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$283K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$272K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$257K |
| 4 |
State Street
Boston,
Massachusetts
|
+$224K |
| 5 |
Two Sigma Advisers
New York
|
+$124K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$666K |
| 2 |
Renaissance Technologies
New York
|
-$197K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$150K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$50.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$32K |
CPIX Hedge Fund Activity: Q4 2021 in Review
26 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2021, worth a combined $13.2M — up 78% from $7.43M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CPIX positions and 4 closed out — a net gain of 3 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $283K. The largest seller was BlackRock, cutting an estimated $666K.
- 26 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2021, up from 23 in Q3 2021.
- Funds reported $13.2M of Cumberland Pharmaceuticals stock for Q4 2021, up 78% quarter-over-quarter.
- 7 funds opened new Cumberland Pharmaceuticals positions in Q4 2021 and 4 closed out, a net change of +3 holders.
- The largest Cumberland Pharmaceuticals buyer in Q4 2021 was Two Sigma Investments, an estimated $283K added.
- The largest Cumberland Pharmaceuticals seller in Q4 2021 was BlackRock, an estimated $666K sold.
Based on aggregated 13F filings for Q4 2021.